Prediction of Trastuzumab Benefit in Adjuvant Breast Cancer: NSABP B31
Disease Events (7)
- DFS - Disease-free survival censoring indicator adjusted for crossover to Herceptin (phv00219076.v1.p1)
- DFStime - Disease-free survival time adjusted for crossover to Herceptin (phv00219077.v1.p1)
- ER - Estrogen receptor status by IHC (phv00219074.v1.p1)
- IS_TUMOR - Tumor status (phv00219084.v1.p1)
- MPSIZ - Pathological tumor size (phv00219075.v1.p1)
- NODE - Number of positive nodes categorized (phv00219078.v1.p1)
- PRIMARY_TUMOR_LOCATION - Primary tumor location (phv00219087.v1.p1)
Other (18)
- ANALYTE_TYPE - Analyte Type (phv00219083.v1.p1)
- BODY_SITE - Body site where sample was collected (phv00219082.v1.p1)
- CONSENT - Consent group as determined by DAC (phv00219065.v1.p1)
- DV_COHORT - Cohort assignment for testing predictive model (phv00219079.v1.p1)
- HISTOLOGICAL_TYPE - Cell or tissue type or subtype of sample (phv00219085.v1.p1)
- PRIMARY_METASTATIC_TUMOR - Primary tumor, metastasis, or transformed cell line (phv00219086.v1.p1)
- SAMPLE_ID - De-identified sample ID (phv00219081.v1.p1)
- SAMPLE_ID - Sample ID (phv00219069.v1.p1)
- SAMPLE_SOURCE - Source repository where samples originate (phv00219070.v1.p1)
- SAMPLE_USE - Sample Use (phv00219072.v1.p1)
- SOURCE_SAMPLE_ID - Sample ID used in the Source Repository (phv00219071.v1.p1)
- SOURCE_SUBJECT_ID - Subject ID used in the Source Repository (phv00219067.v1.p1)
- SUBJECT_ID - De-identified subject ID (phv00219073.v1.p1)
- SUBJECT_ID - Subject ID (phv00219068.v1.p1)
- SUBJECT_ID - De-identified subject ID (phv00219064.v1.p1)
- SUBJECT_SOURCE - Source repository where subjects originate (phv00219066.v1.p1)
- TISSUE_PRESERVATION - Method of preservation (phv00219088.v1.p1)
- TRT - Randomized treatment group (phv00219080.v1.p1)